Copyright
©The Author(s) 2021.
World J Clin Cases. Sep 26, 2021; 9(27): 8061-8070
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8061
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8061
Figure 1 Comparison of the 3-year progression-free and overall survival time.
A: 3-year progression-free survival time; B: Overall survival time. PFS: Progression-free survival; OS: Overall survival.
- Citation: Zhao FJ, Su Q, Zhang W, Yang WC, Zhao L, Gao LY. Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients. World J Clin Cases 2021; 9(27): 8061-8070
- URL: https://www.wjgnet.com/2307-8960/full/v9/i27/8061.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i27.8061